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Normalization of a Ruptured Coronary
Plaque 12 Months After Implantation
of a Bioresorbable ScaffoldTommaso Gori, MD, PHD, Eberhard Schulz, MD, Thomas Münzel, MD
Mainz, GermanyA 61-year-old man with a history of hypertension,
smoking, and hyperlipoproteinemia presented to
our chest pain unit with typical angina. AnFigure 1. Evidence of Anatomical and Functional Normalization After
(A) Right cranial view of the proximal left anterior descending artery show
bioresorbable scaffold. (C) Follow-up at 12 months. (D). Optical coherence
of thickness) on the surface of a subintimal ﬁbroatheroma (dotted line).
and nitroglycerin administration demonstrating improved coronary physi
nitroglycerin (I) also caused vasodilation. BVS ¼ bioresorbable vascular
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the anterior leads, and emergency coronary angi-
ography demonstrated the presence of a rupturedBVS Implantation
ing intravascular thrombosis. (B) After implantation of a 3  18-mm
follow-up at 12 months demonstrating neointimal growth (130 mm
(E to H) Dose-dependent vasodilation in response to acetylcholine
ology 12 months after the acute coronary syndrome. The infusion of
scaffold.plaque in the proximal left anterior descending
coronary artery. The vessel was almost entirely
occluded by an intraluminal thrombus (Fig. 1A).
The lesion was dilated with a 2.75  15-mm
balloon (Maverick, Boston Scientiﬁc, Natick,
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e48Massachusetts) and a 3  18-mm coronary bioresorbable
scaffold (Absorb, Abbott Vascular, Abbott Park, Illinois)
was implanted with a good result (Fig. 1B).
One year later, control angiography demonstrated com-
plete patency of the scaffold (Fig. 1C). Optical coherence
tomography (LightLab C-7, St. Jude Medical, St. Paul,
Minnesota) showed a good apposition and dilation of the
struts. The previously ruptured plaque was covered by a 130-
to 150-mm layer of ﬁbrous neointima (Fig. 1D). Both
acetylcholine (Miochol E, Bausch and Lomb, Rochester,
New York) administered in 3 escalating doses for 3 min each
through a microcatheter placed in the proximal left anterior
descending artery and nitroglycerin 200 mg caused a dose-
dependent coronary vasodilation in the scaffolded segment
(Figs. 1E to 1I).
Data on the outcome of unstable plaques treated with
bioresorbable scaffolds are currently not available. We pro-
vide evidence in support of the concept that, after initial
mechanical stabilization with a bioresorbable scaffold,
biological processes lead to anatomic and physiologicalimprovement of unstable plaques. A moderate neointimal
growth after interventional treatment might in this setting
limit the risk of future exposure of thrombogenic tissues, thus
stabilizing the plaque; similarly, effective vasodilation in
response to acetylcholine reﬂects an improved endothelial
function. Once these processes have occurred, a permanent
metal implant might thus be unnecessary. Temporary plaque
“sealing” with a bioresorbable scaffold should be evaluated
as an alternative to metal stents in the setting of unstable
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